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The 3* end of histone mRNA is formed by an endonucleolytic cleavage of the primary transcript after a
conserved stem-loop sequence. The cleavage reaction requires at least two trans-acting factors: the stem-loop
binding protein (SLBP), which binds the stem-loop sequence, and the U7 snRNP that interacts with a sequence
downstream from the cleavage site. Removal of SLBP from a nuclear extract abolishes 3*-end processing, and
the addition of recombinant SLBP restores processing activity of the depleted extract. To determine the regions
of human SLBP necessary for 3* processing, various deletion mutants of the protein were tested for their ability
to complement the SLBP-depleted extract. The entire N-terminal domain and the majority of the C-terminal
domain of human SLBP are dispensable for processing. The minimal protein that efficiently supports cleavage
of histone pre-mRNA consists of 93 amino acids containing the 73-amino-acid RNA-binding domain and 20
amino acids located immediately next to its C terminus. Replacement of these 20 residues with an unrelated
sequence in the context of the full-length SLBP reduces processing >90%. Coimmunoprecipitation experiments
with the anti-SLBP antibody demonstrated that SLBP and U7 snRNP form a stable complex only in the
presence of pre-mRNA substrates containing a properly positioned U7 snRNP binding site. One role of SLBP
is to stabilize the interaction of the histone pre-mRNA with U7 snRNP.
Unlike all other metazoan mRNAs, the mature 39 ends of
the replication-dependent histone mRNAs do not have poly
(A) tails but are formed instead by an endonucleolytic cleavage
of primary transcripts (pre-mRNAs) downstream from a highly
conserved stem-loop sequence (11). This single-step process-
ing reaction depends on two cis elements present in histone
pre-mRNAs: the stem-loop sequence itself and a purine-rich
sequence located 11 to 12 nucleotides downstream of the
cleavage site and referred to as the histone downstream ele-
ment (HDE) (26). The mature 39 end of histone mRNA con-
sists of a 26-nucleotide sequence including a 6-nucleotide stem
and a 4-nucleotide loop (21) and is recognized by a protein
termed the stem-loop binding protein (SLBP) (29, 45) or the
hairpin binding protein (HBP) (20). Following the cleavage
reaction, SLBP remains associated with the 39 end of mature
histone mRNAs (6, 15). SLBP probably participates in all
critical events in histone mRNA metabolism, including nucleo-
cytoplasmic transport (7, 46), translation (9, 40), and mRNA
degradation (28).
The HDE interacts with the U7 small nuclear ribonucleo-
protein (U7 snRNP), a low-abundance particle present in
about 104 copies per mammalian nucleus, ;1 to 3% of the
amount of the major spliceosomal snRNPs (5, 14, 27). The U7
snRNP contains one molecule of the 63-nucleotide U7 snRNA
and both the common Sm core and the U7 snRNP-specific
proteins (34, 37). Genetic suppression experiments have re-
vealed that binding of the U7 snRNP to the histone pre-
mRNA is mediated at least in part through base pairing be-
tween the 59 end of the U7 snRNA and the HDE (2, 39). The
stem-loop sequence and the SLBP are absolutely required for
39-end processing in vivo (30), but neither is essential for pro-
cessing in vitro if the HDE has sufficient complementarity to
U7 snRNA (38). Cleavage of the histone pre-mRNA occurs
between the two cis elements in a favorable sequence context
containing predominantly adenosine and cytidine residues (8)
and requires a third factor, termed the heat-labile factor (HLF;
12). The heat labile factor, like U7 snRNP, is indispensable for
the 39-end processing and has been primarily characterized by
its sensitivity to a mild heat treatment. Recent studies have
shown that SLBP and the U7 snRNP, and possibly other com-
ponents of the histone pre-mRNA 39 processing machinery,
are found colocalized in spheres, the equivalent of coiled bod-
ies in Xenopus oocytes (1, 48).
Efficient 39-end processing of the histone pre-mRNA de-
pends on proper juxtaposition of the stem-loop sequence and
the HDE. If the distance between the two cis-acting elements
is too small (3) or too large (10, 31, 32), processing is abol-
ished. Moving the HDE only several nucleotides 39 of its nor-
mal position, resulting in a relatively small increase in the
spacing between the stem-loop sequence and the HDE, leads
to both a moderate inhibition of processing and a shift of the
cleavage site by a comparable number of nucleotides (31).
Scharl and Steitz have proposed that U7 snRNP acts as a
molecular ruler, a measuring device which places the cleavage
site at a fixed distance from the site of U7 snRNP binding to
the histone pre-mRNA (31, 32).
SLBP from several species has recently been cloned by using
the three-hybrid system (20, 45) designed for screening RNA
binding proteins in the yeast Saccharomyces cerevisiae (33).
This 31-kDa protein contains a centrally located RNA binding
domain with no similarity to any known motifs that bind RNA
(45). Thus far, SLBP is the only protein component of the
histone pre-mRNA 39 processing machinery available in large
quantities for biochemical analysis. Here we describe experi-
ments aimed at understanding the role of SLBP in the pro-
cessing reaction and determining the minimal regions of the
protein required for cleavage of the histone pre-mRNA. We
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show that a 93-amino-acid fragment retains most of the pro-
cessing activity of SLBP. One role of SLBP is to stabilize the
interaction of the U7 snRNP with the histone pre-mRNA,
thereby increasing the efficiency of the cleavage reaction.
MATERIALS AND METHODS
Construction of the pre-mRNA substrates. The H2a-614 pre-mRNA was gen-
erated by subcloning a 59-nucleotide fragment of the mouse histone H2a-614
gene encompassing the stem-loop structure, the cleavage site, and the HDE
between the KpnI and HindIII sites of the pGEM3 vector (Promega). To facil-
itate construction of H2a derivatives, an EcoRI site was inserted between the
cleavage site and the HDE by alteration of two nonconserved nucleotides. The
H1t and HDE2 clones were generated by replacement of the HDE in the H2a
clone with appropriate sequences (see Fig. 5A) with double-stranded oligonu-
cleotides which were inserted between the EcoRI and HindIII sites. The 4G
clone and the clones with mutant stem-loops were constructed by subcloning the
appropriate double-stranded oligonucleotides between the EcoRI and KpnI sites.
The U7 snRNA clone was constructed by inserting a double-stranded oligonu-
cleotide encoding the 63-nucleotide mouse U7 snRNA (35) between the EcoRI
and HindIII sites of the pGEM3 vector. Clones encoding various HDEs were
generated by inserting the EcoRI-HindIII restriction fragment of H2a, H1t, or
HDE2 constructs into EcoRI and HindIII sites of the pGEM3 vector. Clones
encoding truncated versions of the SLBP were generated by deleting appropriate
regions from the human SLBP gene by using restriction sites previously utilized
to map the RNA binding domain (see Fig. 4A) (45). To construct the SLBP/20aa
clone, the BamHI-PstI fragment in human SLBP cDNA was replaced by the
PCR-amplified fragment encoding amino acids 174 to 193 of Xenopus SLBP2
(43).
Preparation of RNA. The RNA was synthesized by either T7 or SP6 RNA
polymerase with DNA templates linearized with either HindIII or EcoRI restric-
tion enzymes, respectively. The transcription reaction was carried out in the
absence of radioisotopes in a final volume of 150 ml according to a standard
protocol. The RNA was subsequently gel purified to remove pretermination
products. The 59 phosphates of the RNA were removed by treatment with the
calf intestinal phosphatase (Boehringer Mannheim), and 50 ng of dephosphory-
lated RNA was subsequently radiolabeled with 30 mCi of [g-32P]ATP and 5 U of
T4 polynucleotide kinase (New England Biolabs). The RNA was separated from
the unincorporated ATP by G-50 spin columns (Pharmacia) and used without
additional purification. The in vitro processing reactions were carried out in the
presence of 86-nucleotide pre-mRNA substrates. Each substrate contained 59
nucleotides encompassing all cis elements required for processing and 22 and 5
nucleotides of pGEM3 vector (Promega) on 59 and 39 RNA flanks, respectively.
The U7 snRNA was detected on Northern blots by hybridization with radiola-
beled RNA containing a 63-nucleotide region complementary to the U7 snRNA
and 13 and 5 nucleotides of vector sequences on the 59 and 39 ends, respectively.
This RNA was synthesized in the antisense orientation from the U7 snRNA
construct in the presence of 10 mM unlabeled CTP and 50 mCi of [a-32P]CTP.
The remaining nucleoside triphosphates were used at a 500 mM concentration.
The unlabeled RNA containing the U7 snRNA sequence used as an internal
control for the Northern blots was synthesized from the U7 snRNA construct in
the sense orientation. The reaction was carried out in the absence of radioiso-
topes in a final volume of 150 ml, and the RNA was purified as described above.
The stem-loop RNA oligonucleotides used in band shift assays and competition
experiments were synthesized by T7 RNA polymerase with the appropriate
oligonucleotide templates (24).
Nuclear extract preparation and in vitro processing. Nuclear extracts were
prepared from mouse myeloma cells as described previously (6, 22). Each pro-
cessing reaction was carried out in a total volume of 10 ml containing 5 ml of the
nuclear extract, 5 ng of the pre-mRNA substrate labeled at the 59 end with
[g-32P]ATP, and 20 mM EDTA. Samples were incubated at 32°C for 60 min, and
the RNA was isolated and analyzed as previously described (6, 22). Since the
efficiency of in vitro processing reactions varied significantly, depending on the
preparation of the nuclear extract and the batch of the pre-mRNA substrate,
each experiment was accompanied by appropriate controls. Whenever possible,
a complete set of experiments was carried out with the same preparation of the
nuclear extract.
Expression and purification of the SLBP. Wild-type and mutant forms of the
SLBP were expressed in Sf9 insect cells with the baculovirus expression system
(Gibco BRL), as recommended by the manufacturer. For preparative purifica-
tion, 200 ml of the infected cell culture was grown for 72 h, and the SLBP was
purified by chromatography on Ni-agarose, as recommended. The typical yield
was 200 to 500 mg of the pure protein.
Preparation of the SLBP-depleted extract and complementation of the in vitro
processing reaction. The endogenous SLBP was removed from the nuclear
extract with either the biotinylated RNA containing the stem-loop structure, as
previously described (6), or anti-SLBP antibody, essentially as previously de-
scribed (22, 45). Each preparation of the depleted extract was tested for pro-
cessing activity both alone and in the presence of the full-length human recom-
binant SLBP. To complement the in vitro processing reaction, approximately 20
to 50 ng of baculovirus-expressed SLBP was added to 5 ml of the depleted extract.
Mobility shift assay. The nuclear extract (2.5 ml; 12.5 mg of protein) or pure
SLBP expressed in Sf9 insect cells (50 ng) was mixed on ice with 1 ng of the 59
labeled 30-nucleotide stem-loop RNA and immediately applied to 6 to 8% native
polyacrylamide gels containing 13 Tris-borate–EDTA buffer. The complexes
were resolved by electrophoresis and detected by autoradiography.
Western blots. Proteins from nuclear extracts were separated on sodium do-
decyl sulfate (SDS)–12% polyacrylamide gels and transferred to nitrocellulose
filters. The SLBP was detected with antibody against the C-terminal 13 amino
acids of the protein (45) by using the ECL system (Amersham).
Immunoprecipitation of processing complexes and detection of the U7
snRNA. An equivalent of 10 individual processing reaction mixtures, containing
50 ng of unlabeled RNA substrate, 50 ml of the nuclear extract, and 20 mM
EDTA, was set up on ice in a total volume of 100 ml and incubated for 5 min at
22°C to allow complex formation. Ten microliters of anti-SLBP antibody purified
on protein A agarose was added, and the samples were rotated at 4°C for 1.5 h
and then transferred to a new tube containing 20 ml of protein A agarose beads.
The protein A agarose beads were preincubated in a nuclear extract from sea
urchin blastula nuclei (17) and washed with buffer to reduce nonspecific binding.
The samples were rotated for 1.5 h, and the beads were collected, rinsed twice
with buffer D (20 mM HEPES-KOH [pH 7.9], 100 mM KCl, 0.5 mM dithiothre-
itol, 0.2 mM EDTA [pH 8.0], 20% glycerol) containing 0.1% Nonidet P-40
detergent, suspended in 1 ml of the same buffer, and rotated at 4°C for an
additional 1.5 h. The protein A agarose beads were suspended in 100 ml of 0.3 M
sodium acetate containing 10 mg of glycogen and 0.1 ng of the in vitro-synthe-
sized U7 snRNA, and the mixture was extracted with phenol. The RNA was
recovered by precipitation with ethanol, resolved on an 8.5% polyacrylamide–7
M urea denaturing gel, and transferred to a HyBond-N1 membrane (Amer-
sham) by using the Genie electrophoretic blotter (Idea Scientific). The blot was
irradiated with UV light in a Stratalinker apparatus (Stratagene), preincubated
in Quikhyb solution (Stratagene) for 1 h at 62°C, and then hybridized overnight
at the same temperature with antisense U7 snRNA probe (105 cpm). Following
several washes in 0.015 M NaCl, 0.0015 M Na3 citrate, and 0.1% SDS at 62°C, the
U7 snRNA was detected by autoradiography.
RESULTS
Importance of high-affinity binding of SLBP in histone pre-
mRNA processing. SLBP binds with high affinity to a con-
served 26-nucleotide sequence immediately preceding the 39
cleavage site in nonpolyadenylated histone pre-mRNAs. This
sequence consists of a 16-nucleotide stem-loop structure
flanked on either side by five conserved nucleotides (21). As
shown by mobility shift assays and competition experiments,
mutations in any region of this sequence affect its binding to
SLBP (47). In vitro processing of commonly used histone pre-
mRNA substrates, including the H2a-614 pre-mRNA, is not
absolutely dependent on SLBP and the stem-loop sequence (6,
25, 38). When binding of SLBP to the H2a-614 substrate is
prevented by removing the protein from the extract or by using
a high molar excess of a 30-nucleotide competitor RNA con-
taining the wild-type stem-loop sequence, the processing reac-
tion still proceeds with 5 to 10% efficiency (6, 45). A similar
reduction in processing efficiency is achieved by reversing the
sequence of the stem in the H2a-614 pre-mRNA (RS; Fig. 1A,
lane 7). The RS mutation virtually abolishes binding of SLBP
to the stem-loop sequence as demonstrated by the inability of
the mutant RNA oligonucleotide to form any detectable com-
plex in a mobility shift assay and to effectively compete with the
wild-type sequence for SLBP binding (47; Fig. 1C). In order to
determine the importance of high-affinity binding of SLBP to
the pre-mRNA in 39-end processing, the stem-loop sequence
of H2a pre-mRNA was altered by mutations having a less
drastic effect on SLBP binding than the RS mutation. The
mutant pre-mRNA substrates were subsequently tested in the
in vitro processing assay with a nuclear extract from mouse
myeloma cells. Base substitutions altering the conserved base
pair at the top of the stem from UA to AU, CG, or UG result
in 5- to 10-fold-lower affinity of SLBP for the stem-loop se-
quence (47). These mutations decreased processing efficiency
from approximately 60% for the wild-type substrate (Fig. 1A,
lane 1) to less than 20% (Fig. 1A, lanes 2 to 4). A much
stronger effect on the in vitro processing was exerted by a
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1-nucleotide expansion of the loop (U4C; Fig. 1A, lane 6) or
alteration of the region 59 to the stem-loop (59FL; Fig. 1A, lane
5). These two mutations reduced cleavage efficiency to a level
comparable with the RS mutation (5 to 10%). Interestingly,
while the RNA oligonucleotide containing the RS mutation
had very low affinity for SLBP (Fig. 1C, lanes 9 and 10), the
U4C and 59FL RNAs at high concentrations were able to
compete binding of SLBP to the wild-type RNA (Fig. 1C, lanes
5 to 8). Binding of the wild-type sequence to SLBP was re-
duced at least 90% with a 100-fold excess of these RNAs and
abolished with a 500-fold molar excess of these RNAs (Fig. 1C,
lanes 5 and 8, respectively). The RS mutant RNA was inactive
even at a 1,000-fold excess (Fig. 1C, lane 11) (47), while the
wild-type competitor completely abolished binding of radiola-
beled probe to SLBP at an excess of 20-fold (data not shown)
and greater (Fig. 1C, lanes 3 and 4) (6, 47). These results
indicate that high affinity of SLBP for the histone pre-mRNA
substrate is required to effectively support 39 processing in
vitro as it does in vivo (30).
Construction of a processing substrate absolutely depen-
dent on SLBP. The requirement for SLBP in the processing
reaction varies among different substrates and depends on the
extent of complementarity between the U7 snRNA and the
HDE (38). Substrates containing very strong HDEs, e.g., the
mouse H4-12 pre-mRNA, are actually cleaved with normal
efficiency in some nuclear extracts in which SLBP is seques-
tered by the wild-type stem-loop RNA oligonucleotide (38).
Under the same conditions, the cleavage efficiency of the H2a-
614 pre-mRNA containing a weaker HDE declines to 5 to 10%
of the control level (6) (Fig. 2). Based on these observations it
has been proposed that SLBP functions in processing by sta-
bilizing the interaction of the U7 snRNP with the HDE in the
histone pre-mRNA (38).
Since the presence of SLBP-independent processing will ob-
scure understanding of the role played by SLBP in the cleavage
reaction, we constructed a substrate fully dependent on SLBP.
Histone pre-mRNA encoded by the histone H1 gene specifi-
cally expressed in testis (H1t) is unique among natural pro-
cessing substrates in that its HDE substantially departs from
the consensus sequence and displays only limited complemen-
tarity to the U7 snRNA (44) (Fig. 2A). The HDE in the
histone H2a-614 pre-mRNA can form a nearly perfect duplex
with U7 snRNA, consisting of 14 bp (including 2 GU pairs),
interrupted by only one mismatch. The HDE in the H1t pre-
mRNA can form only 11 bp separated by several noncomple-
mentary nucleotides (Fig. 2A). Moreover, the H1t HDE has
relatively weak complementarity to the CUCUUU sequence
(nucleotides 12 to 17 of the U7 snRNA) which base pairs with
the core of the HDE in the somatic histone pre-mRNAs (2)
and instead has the potential to base pair with the extreme 59
end of the U7 snRNA. Additional base pairs with the pre-
mRNA substrate and this region of the U7 snRNP have been
reported previously for other histone pre-mRNAs (36). We
reasoned that both the decreased number and more sparse
distribution of base pairs formed between the H1t pre-mRNA
and the U7 snRNA should result in a relatively weak interac-
tion between the two RNAs. To demonstrate that the H1t
HDE has a lower affinity for the U7 snRNP than the H2a-614
HDE, we synthesized RNA competitors containing either the
H2a-614 or H1t HDE. Each RNA competitor was added to the
in vitro processing reaction at a 100-fold molar excess over the
H2a-614 pre-mRNA substrate and tested for its ability to affect
efficiency of the cleavage. About 90% of the H2a-614 pre-
mRNA was processed in the absence of any RNA competitor
(Fig. 2B, lane 1). The cleavage reaction proceeded with similar
efficiency in the presence of a 100-fold molar excess of a con-
trol RNA competitor with no complementarity to the U7
snRNA (Fig. 2B, lane 2). Competitor RNA containing the
H2a-614 HDE virtually abolished processing (.95% reduction
of the initial efficiency; Fig. 2B, lane 3), presumably by binding
to the 59 end of the U7 snRNA and inactivating the U7 snRNP
in the nuclear extract. The RNA oligonucleotide containing
the H1t HDE at the same concentration had no effect (Fig. 2B,
lane 4). These results show that the extent of base pairing
FIG. 1. Effect of altering the affinity of the pre-mRNA for SLBP. (A) Each
of the six mutant stem-loops shown was introduced into the mouse histone
H2a-614 pre-mRNA. The radiolabeled synthetic pre-mRNAs were incubated for
30 min in a nuclear extract prepared from mouse myeloma cells, as described in
Materials and Methods. The RNA was purified, resolved by gel electrophoresis,
and detected by autoradiography. The input pre-mRNA (top band) and the
shorter cleavage product (bottom band) are indicated. (B) Sequence of 26
nucleotides encompassing the stem-loop structure in the various mutants. (C)
Thirty-nucleotide RNAs were synthesized by T7 RNA polymerase with the
appropriate oligonucleotide templates. Each RNA consists of 26 nucleotides
encompassing the stem-loop structure shown and the GCCC sequence at the 59
end facilitating synthesis of RNA by T7 polymerase. The 30-nucleotide RNA
containing the wild-type stem-loop structure was labeled at the 59 end with
[g-32P]ATP and used to detect SLBP in the nuclear extract (NE) by using a
mobility shift assay. The samples were analyzed on a 7% polyacrylamide gel
under nondenaturing conditions. Unlabeled 30-nucleotide RNA competitors
containing the wild-type or mutant stem-loop sequences were added to the
reaction at a molar excess, as indicated above each lane. Lanes 2 and 9, no
competitor added; lane 1, probe.
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between the H1t HDE and the 59 end of the U7 snRNA is not
sufficient to allow stable binding of the U7 snRNP to this
competitor RNA.
The 86-nucleotide histone H1t pre-mRNA substrate was
constructed by substituting the HDE in the histone H2a-614
pre-mRNA with the corresponding element from the H1t pre-
mRNA. The H1t pre-mRNA was processed in vitro at least
50% as efficiently as the H2a-614 substrate. To compare the
dependence of processing of the H1t pre-mRNA on SLBP, we
carried out the reaction in the presence of competitor RNA
capable of titrating out SLBP from the nuclear extract. A
100-fold molar excess of 30-nucleotide RNA containing the
wild-type stem-loop structure prevents binding of SLBP to the
pre-mRNA substrate and causes substantial reduction, but not
complete inhibition, of the processing of the H2a-614 pre-
mRNA (6) (Fig. 2C, top panel, lane 2). Processing of the
histone H1t pre-mRNA substrate is abolished under the same
conditions (Fig. 2C, bottom panel, lane 2). Complete depen-
dence of H1t pre-mRNA processing on SLBP was further
confirmed by using RNA competitors that have lower affinity
for SLBP due to either a uridine insertion in the loop (SLU4C,
Fig. 1B) or placing a UUUG sequence 59 to the stem-loop (59
FL; Fig. 1B). Each competitor at a 100-fold molar excess al-
most completely inhibited cleavage of the H1t pre-mRNA
(Fig. 2C, bottom panel, lanes 4 and 5) but had only a moderate
effect on processing of the H2a substrate (Fig. 2C, top panel,
lanes 4 and 5). At the same concentrations, these competitors
reduced binding of SLBP to the wild-type stem-loop probe
more than 95% as determined by the mobility shift assay (Fig.
1C). Addition of the RS RNA competitor, which has the stem
sequence reversed (Fig. 1B) and at least a 100-fold-lower af-
finity for SLBP (47), did not affect processing of either sub-
strate (Fig. 2C, lane 3, both panels). The differential effect of
the U4C and 59FL oligonucleotides on processing of the two
substrates is discussed below (see Discussion). We conclude
that SLBP is an essential and indispensable trans-acting factor
in the in vitro 39-end processing of the H1t pre-mRNA. This
substrate was used in the majority of the subsequent experi-
ments.
Complementation of the SLBP-depleted extract with recom-
binant baculovirus SLBP. We have previously shown that de-
pleting the SLBP from the nuclear extract with anti-SLBP
antibody has an effect similar to that caused by the addition of
an excess of the stem-loop RNA to the reaction and results in
a substantial decrease in the processing of the histone H2a-614
pre-mRNA (45). To definitively show that removal of SLBP is
solely responsible for the reduced efficiency of the reaction, we
developed a complementation assay in which the depleted
extract was supplemented with recombinant SLBP. Both the
H2a-614 and the H1t pre-mRNAs were used as substrates to
assess processing activity of the reconstituted nuclear extract.
With an antibody to the 13 C-terminal amino acids of SLBP
(45), more than 95% of SLBP was removed from the extract,
as determined both by mobility shift assay (Fig. 3A, lane 5) and
by Western blotting (Fig. 3D, lane 3). Depletion of SLBP
resulted in a decrease in processing efficiency of the histone
H2a pre-mRNA substrate from approximately 90 to about
10% (Fig. 3B, top panel, lane 4) and completely abolished
processing of the H1t substrate (Fig. 3B, bottom panel, lane 4).
An identical reduction in processing efficiency was caused by
sequestering SLBP by addition of an excess of wild-type SL
RNA competitor (Fig. 3B, lane 2). Mock depletion carried out
with preimmune serum caused irreversible loss of some (about
25%) of the processing activity (Fig. 3B, lane 3) but did not
significantly affect the amount of SLBP, as demonstrated by
the mobility shift assay (Fig. 3A, lane 4). This loss of activity is
most likely a result of prolonged incubation at 4°C or of non-
specific adsorption of processing factors to the protein A beads.
Recombinant human SLBP containing a histidine tag at the
N terminus was expressed in Sf9 insect cells by using the
baculovirus system and purified by Ni affinity chromatography.
Complementation of the SLBP-depleted extract with the ex-
ogenous protein restored both SLBP binding activity (Fig. 3A,
lane 6) and processing of the H2a-614 and H1t pre-mRNA
substrates (Fig. 3B, lane 5, both panels). Addition of the SLBP
to a complete extract resulted only in a slight stimulation of
processing, suggesting that SLBP is not the limiting component
of the processing extract (data not shown).
SLBP was also removed from the nuclear extract via binding
to a biotinylated 30-nucleotide RNA containing the wild-type
FIG. 2. Comparison of H2a-614 and H1t pre-mRNAs as processing sub-
strates. (A) The sequences of the H2a and H1t pre-mRNAs encompassing the
stem-loop and HDE are shown. The sequence of the 59 end of the U7 snRNA
and its potential to form base pairs with the HDE are depicted below each
pre-mRNA substrate. Watson-Crick base pairs are indicated by vertical lines,
and GU base pairs are indicated by dots. (B) The 86-nucleotide H2a-614 pre-
mRNA substrate was incubated in a nuclear extract (NE) for 60 min under
processing conditions (lane 1). RNA oligonucleotides containing the sequence of
either the mutant HDE (HDE2) (see Fig. 5A), the H2a-614 HDE, or the H1t
HDE were added to the reaction samples at a 100-fold molar excess relative to
the substrate (lanes 2, 3, and 4, respectively). The RNA was purified, resolved by
gel electrophoresis, and detected by autoradiography. (C) The in vitro processing
reaction was carried out with either the H2a-614 (top panel) or H1t (bottom
panel) pre-mRNAs under standard conditions (lane 1) or in the presence of a
100-fold molar excess of the competing 30-nucleotide RNAs shown in Fig. 1B, as
indicated above each lane (lanes 2 to 5).
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stem-loop sequence followed by adsorption of RNA-protein
complexes to streptavidin beads (6, 20). Unlike immunodeple-
tion, RNA-mediated depletion may result in removal of factors
other than SLBP that bind to the stem-loop sequence. On the
other hand, this approach would not lead to removal of inac-
tive SLBP molecules unable to bind RNA. This procedure was
equally effective in depleting SLBP from the nuclear extract, as
assayed by mobility shift (6) and Western blotting (Fig. 3D,
lane 5) and resulted in the same reduction of processing effi-
ciency as immunodepletion (Fig. 3C, lane 2, both panels).
Processing of both the H2a and the H1t pre-mRNA substrates
was restored to the initial level by addition of the recombinant
human SLBP to the depleted extract (Fig. 3C, lane 5). This
result demonstrates that no other essential processing factors
are quantitatively bound to the SLBP-RNA complex and re-
moved from the extract during RNA-mediated SLBP depletion.
Mapping of the regions of SLBP involved in histone pre-
mRNA processing. In order to determine which regions of
human SLBP participate in processing of the histone pre-
mRNA, truncated versions of SLBP were expressed in the
baculovirus system and tested for their ability to complement
immunodepleted nuclear extract. All deletions were made out-
side the central region of SLBP encompassing the RNA bind-
ing domain (Fig. 4A). As determined by mobility shift assays,
all the mutant proteins bound the stem-loop RNA (data not
shown) (45). Complementation experiments were carried out
in the immunodepleted nuclear extract by using the H1t pre-
mRNA as a processing substrate. Due to a small amount of
SLBP left in this depleted extract, processing of the H1t sub-
strate was not completely abolished but proceeded with about
5% efficiency (Fig. 4B, lane 2).
The baculovirus-expressed deletion proteins D13C, D68N-
D13C, and D124N-D13C restored activity of the depleted ex-
tract to control levels (Fig. 4B, lanes 4, 6, and 7, respectively),
indicating that the last 13 amino acids of the protein and the
entire 124 amino acids of the N-terminal domain are not nec-
essary for processing. The D52C mutant protein, which con-
tains only 20 amino acids after the RNA binding domain,
restored processing activity to 40% of the control level (Fig.
4B, lane 5). Since deletion of the 13 C-terminal amino acids did
not affect the activity of SLBP, we conclude that the remaining
39 amino acids (amino acids 218 to 256) play a role in enhanc-
ing the processing efficiency. A recombinant fragment of SLBP
containing only the RNA binding domain did not have any
activity in processing (Fig. 4B, lane 8; Fig. 4C, lane 5), although
it bound the stem-loop RNA with high affinity (Fig. 4D, lane 5).
Deletion mutagenesis suggested that a 93-amino-acid frag-
ment of SLBP, containing only the RNA binding domain and
subsequent 20 amino acids, has processing activity. This pro-
tein (hSLBP/min) was expressed in baculovirus and tested for
its ability to complement the immunodepleted extract. The
hSLBP/min restored processing to 40% of the control level
(Fig. 4C, lane 4), similar to the activity of the D52C deletion
protein (Fig. 4B, lane 5). To definitively confirm the impor-
tance of the 20 amino acids after the RNA binding domain, we
replaced this region in the intact SLBP with an unrelated
sequence. We used the sequence found adjacent to the RNA
binding domain of the Xenopus SLBP2, a protein that does not
FIG. 3. Depletion of SLBP from the nuclear extract and complementation with recombinant SLBP. (A) The 30-nucleotide radiolabeled wild-type stem-loop RNA
(lane 1) was incubated in a nuclear extract (NE), and the complex was resolved by gel electrophoresis (lane 2). Lane 3, nuclear extract plus a 100-fold excess of unlabeled
competitor 30-nucleotide stem-loop RNA; lane 4, extract treated with preimmune serum (mock depletion); lane 5, extract depleted with anti-SLBP antibody; lane 6,
anti-SLBP-depleted extract supplemented with 50 ng of recombinant human SLBP. (B) The same extracts as those in panel A were used in processing reactions with
the histone H2a-614 pre-mRNA (top panel) or the H1t pre-mRNA substrates (bottom panel). The RNAs were purified, resolved by electrophoresis in a denaturing
polyacrylamide gel (8%; 7 M urea), and detected by autoradiography. Processing in the nuclear extract (NE) under standard conditions and in the presence of a 100-fold
excess of 30-nucleotide competitor RNA with wild-type stem-loop sequence is shown in lanes 1 and 2, respectively. Lane 3, mock-depleted extract (preimmune serum);
lane 4, extract depleted with anti-SLBP antibody; lane 5, anti-SLBP-depleted extract plus recombinant human SLBP. (C) Processing of the histone H2a-614 pre-mRNA
(top panel) or the H1t pre-mRNA (bottom panel) in the nuclear extract depleted of SLBP with biotinylated RNA oligonucleotide containing the wild-type stem-loop.
Lane 1, mock-depleted extract (nonspecific biotinylated oligonucleotide); lane 2, extract depleted with biotinylated stem-loop RNA; lane 3, depleted extract
complemented with 50 ng of recombinant human SLBP. (D) Equal amounts (50 mg of protein) of the nuclear extracts (NE) used in panels B and C were resolved by
electrophoresis on a 12% polyacrylamide–SDS gel, and SLBP was detected by Western blotting. The top band represents the intact 45-kDa SLBP, and the bottom band
is a proteolytic cleavage product lacking part of the N terminus of the protein.
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function in histone pre-mRNA processing (43). This protein,
hSLBP/20aa, bound strongly to the stem-loop (Fig. 4D, lane 3)
but retained only slight activity in stimulating the cleavage
reaction (,5%; Fig. 4C, lane 6). Thus, in vitro processing
requires only high-affinity binding of the SLBP to the RNA
target via its RNA binding domain and the 20 amino acids
adjacent to the C terminus of this domain.
Coprecipitation of the U7 snRNP with SLBP and histone
pre-mRNA. To initiate studies on the function of SLBP in the
processing reaction, we used the anti-SLBP antibody to isolate
any complexes that might form on the histone pre-mRNA.
Since time course experiments indicate that histone pre-
mRNA processing proceeds without a significant time lag (6,
11, 27), reactions containing an unlabeled pre-mRNA sub-
strate and nuclear extract were briefly (5 min) incubated at
22°C (below the optimum 32°C) to allow complex formation
and immediately cooled on ice. As determined by using radio-
labeled substrate, incubation under these conditions resulted
in binding of more than 95% of the pre-mRNA to SLBP and
yielded less than 2% of the cleavage product (data not shown).
Anti-SLBP antibody was then added to the reactions, and
complexes were isolated by binding to protein A-agarose.
RNA was recovered from the immunoprecipitates, and the U7
snRNA was detected by Northern analysis. More than 95% of
the substrate RNA was recovered in the immunoprecipitates
(data not shown), since SLBP is present in excess over the
substrate in these reactions. An internal standard RNA con-
taining the U7 snRNA sequence was added to each sample
prior to phenol extraction to control for the efficiency of RNA
isolation and hybridization.
Only a small amount of the U7 snRNA bound nonspecifi-
cally to the protein A-agarose in the absence of the pre-mRNA
substrate (Fig. 5C, lane 1). After addition of unlabeled H2a
pre-mRNA large amounts of U7 snRNP coimmunoprecipi-
tated with SLBP (Fig. 5C, lane 2). Precipitation of the U7
snRNP was specific, since it was completely abolished by se-
questering the antibody with the antigenic peptide (Fig. 5C,
lane 3). Coimmunoprecipitation of the U7 snRNP in the pres-
ence of H2a pre-mRNA was also abolished by addition of a
29-O-methyl oligoribonucleotide complementary to the first 19
nucleotides of the U7 snRNA (Fig. 5C, lane 5) and was not
affected by a large excess of a nonspecific 29-O-methyl oligo-
ribonucleotide (Fig. 5C, lane 4). The anti-U7 29-O-methyl oli-
goribonucleotide has been previously shown to completely in-
hibit the cleavage reaction by masking the 59 end of the U7
snRNA and preventing the U7 snRNP from base pairing with
the HDE (4, 6, 31). This result demonstrates that stable bind-
ing of the U7 snRNP to the substrate requires base pairing
between the 59 end of the U7 snRNA and the pre-mRNA
substrate. Consistently, the HDE mutant substrate, which can-
not base pair with the U7 snRNA (Fig. 5A), is inactive in
processing (Fig. 5B, lane 2) and is not able to form a stable
complex with the U7 snRNP (Fig. 5C, lane 9). No U7 snRNA
was recovered when the H2a/RS substrate containing the re-
versed stem sequence was used (Fig. 5C, lane 10). This muta-
tion virtually abolishes binding of SLBP to the histone pre-
mRNA and prevents immunoprecipitation of the substrate by
anti-SLBP antibody. Finally, coimmunoprecipitation of the U7
snRNP was completely blocked by the addition of excess stem-
loop RNA oligonucleotide which sequestered all free SLBP
and prevented binding of SLBP to the pre-mRNA substrate
(Fig. 5C, lane 6). This result demonstrates that the SLBP–
stem-loop RNA complex formed under these conditions does
not stably associate with the U7 snRNP and confirms that
stable interaction between the two factors requires that both
cis-acting elements be present on the same pre-mRNA mole-
cule.
Guanosines are not found at the cleavage site of any natural
histone pre-mRNAs, and substitution of guanosine for cytosine
at this site greatly reduces processing (8). We constructed the
H2a/4G mutant substrate derived from the H2a pre-mRNA by
replacing the CACU sequence at the cleavage site with four
guanosines (Fig. 5A). The H2a/4G substrate was inactive in
processing (Fig. 5B, lane 1). In spite of that, the H2a/4G
pre-mRNA supported formation of stable complexes with U7
FIG. 4. Regions of human SLBP required for histone pre-mRNA processing.
(A) The restriction map of the human SLBP cDNA with the boundaries of the
three regions of the protein corresponding to the N-terminal domain (N-ter), the
RNA binding domain (RBD), and the C-terminal domain (C-ter) is outlined at
the top. The constructs are named according to the number of amino acids
deleted from the N or C terminus. The hSLBP/20aa has the 20 amino acids
immediately after the RNA binding domain (196 to 215) changed to the 20
amino acids present at this position in frog XSLBP2, an SLBP which does not
function in pre-mRNA processing (43). The ability of the mutant SLBP to
restore processing in the SLBP-depleted extract is summarized to the right of
each construct. (B) The nuclear extract (lane 1) was depleted of SLBP with
anti-SLBP antibody and was assayed for the ability to cleave the H1t pre-mRNA
when complemented with 50 ng of the indicated mutant human SLBP. Depletion
of the extract resulted in an almost complete loss of processing activity (lane 2)
which was fully restored when the depleted extract was supplemented with the
full-length human SLBP (lane 3). Complementation of the depleted extract with
the mutant proteins is shown in lanes 4 to 8. (C) Processing activity of the nuclear
extract (NE; differing from that in Fig. 1B) before and after immunodepletion is
shown in lanes 1 and 2, respectively. Fifty nanograms of human SLBP (lane 3) or
mutant proteins was added to the depleted extract, as indicated (lanes 4 to 6).
(D) The recombinant proteins were tested for their ability to bind to the stem-
loop RNA oligonucleotide. Fifty nanograms of the recombinant protein indi-
cated at the top of each lane was incubated with the radiolabeled stem-loop
RNA, and the complexes were resolved by native gel electrophoresis.
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snRNP with an efficiency similar to that of the parental H2a
substrate (Fig. 5C, lane 7). Thus, stable association with the U7
snRNP is necessary but not sufficient for cleavage of histone
pre-mRNAs. The H1t pre-mRNA, which contains a weaker
HDE than the H2a and H2a/4G pre-mRNAs, was significantly
less efficient in the formation of stable complexes with U7
snRNP. This substrate bound about 25% of the amount of U7
snRNA immunoprecipitated with H2a-614 pre-mRNA (Fig.
5C, lane 8).
We conclude from the above results that histone pre-
mRNAs support formation of a stable processing complex
containing SLBP and the U7 snRNP.
Function of SLBP in processing. The above immunoprecipi-
tation experiments confirmed previous results that the U7
snRNP and the histone pre-mRNA can form a stable complex
dependent on base pairing between the U7 snRNA and the
HDE but did not definitively show that SLBP is required for
this interaction. Since in our experiments isolation of the pro-
cessing complexes is dependent on the anti-SLBP antibody,
mutating the stem-loop structure to prevent binding of the
SLBP to the pre-mRNA or removing SLBP from the extract
prevents subsequent isolation of the histone pre-mRNA sub-
strate.
Increasing the distance between the stem-loop structure and
the HDE results in a shift of the cleavage site by a comparable
number of nucleotides (31, 32). In addition to movement of the
cleavage site, insertions between the stem-loop and the HDE
result in a progressive decline of processing efficiency as the
distance between the two elements increases, leading eventu-
ally to a complete loss of activity (31, 32). To determine
whether the spacing between the stem-loop and the HDE was
critical for stable association of U7 snRNP with the pre-
mRNA, we constructed the H2a/14 and H2a/112 pre-mRNA
substrates by inserting 4 or 12 nucleotides between the cleav-
age site and the HDE, respectively (Fig. 6A). The inserted
sequences were compatible with known cleavage specificity,
containing highly preferred adenosine residues (8) or a dupli-
FIG. 5. Formation of a stable complex containing the SLBP and the U7
snRNP on the pre-mRNA substrate. (A) Sequences of the substrates used for
assaying U7 snRNP binding. The sequence of the parental H2a pre-mRNA
comprising the stem-loop structure, the cleavage site represented by an arrow,
and the U7 binding site are shown at the top. The nucleotides at the 59 and 39
ends of the RNA encoded in the pGEM3 vector are not included. The nucleotide
substitutions introduced into the H2a pre-mRNA in order to generate the other
pre-mRNA substrates are shown below the H2a sequence. The unchanged se-
quences are represented by solid lines. The RS mutant of the H2a-614 pre-
mRNA contains reversed sequence of the stem-loop structure, as shown in Fig.
1B. (B) The H2a/4G (lane 1) and HDE2 (lane 2) substrates shown in panel A
were incubated in a nuclear extract under standard processing conditions. The
RNA was analyzed as described in the legend to Fig. 2. (C) The H2a-614
substrate (lanes 2 to 6) and the indicated mutant substrates (lanes 7 to 10) were
briefly incubated in nuclear extract to allow the formation of processing com-
plexes. The complexes were immunoprecipitated with anti-SLBP antibody, RNA
prepared, resolved by electrophoresis on 8.5% polyacrylamide gel containing 7
M urea, and assayed for the presence of U7 snRNA by Northern blotting.
Immunoprecipitation was carried out in the presence of the H2a-614 pre-mRNA
(lanes 2 to 6) or mutant pre-mRNAs, as indicated (lanes 7 to 10). Lane 1, no
substrate added; lane 3, 10 mg of antigenic peptide was added to the reaction
mixture prior to addition of the antibody; lanes 4 and 5, immunoprecipitation in
the presence of 0.5 mg of a nonspecific 29-O-methyl oligoribonucleotide or
29-O-methyl oligoribonucleotide complementary to the 59 end of U7 snRNA,
respectively. Lane 6, immunoprecipitation in the presence of a 100-fold excess of
the 30-nucleotide RNA containing the stem-loop sequence. Control, 0.1 ng of a
synthetic 77-nucleotide RNA containing the complete sequence of the U7
snRNA added to each sample as an internal standard for RNA recovery and
hybridization efficiency.
FIG. 6. The stimulation of binding of the U7 snRNP by SLBP is distance
dependent. (A) The sequence of the H2a-614 mutant substrates containing
either 4- or 12-nucleotide insertions between the normal cleavage site and the
HDE. (B) The radiolabeled substrates shown in panel A and indicated above
each lane were incubated in nuclear extract under standard processing condi-
tions, and RNA was analyzed as described above. (C) The anti-SLBP antibody
was used to isolate processing complexes assembled on the pre-mRNA sub-
strates, as described in Fig. 5C. Immunoprecipitation with no pre-mRNA added
(lane 1) or in the presence of the substrates shown in panel A (lanes 2 to 4). (D)
The anti-SLBP antibody was used to isolate processing complexes assembled on
the H2a-614 substrate (lanes 2 and 3) in the control nuclear extract (NE) or in
extract which had been heat inactivated at 50° for 15 min. Lane 1, no RNA was
added to the control extract.
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cated cleavage site (H2a/14 and H2a/112 pre-mRNA, respec-
tively; Fig. 6A). The H2a/14 construct was processed relatively
efficiently, and in agreement with the results of Scharl and
Steitz (31), the cleavage site was shifted about four nucleotides
downstream of the wild-type site (Fig. 6B, lane 2). The H2a/
112 substrate was essentially inactive in processing (Fig. 6B,
lane 3), although longer exposures resulted in detection of
minor products resulting from cleavage 10 to 15 nucleotides 39
of the wild-type site (data not shown). The overall efficiency of
processing at these sites approximately equaled the efficiency
of SLBP-independent processing of the H2a-614 substrate,
suggesting that large insertions between the stem-loop and the
HDE are functionally equivalent to mutating the stem-loop or
depleting SLBP from the nuclear extract.
In order to determine the ability of the H2a/14 and H2a/
112 pre-mRNAs to form stable complexes with U7 snRNP,
each substrate was incubated in the nuclear extract to form
processing complexes that were subsequently immunoprecipi-
tated by the anti-SLBP antibody and analyzed for the presence
of the U7 snRNA. The H2a/14 pre-mRNA supported forma-
tion of processing complexes containing the U7 snRNP at least
as efficiently as the control H2a pre-mRNA (Fig. 6C, lanes 2
and 3, respectively), although it was less efficiently processed
(Fig. 6B, lane 2). Strikingly, immunoprecipitation of processing
complexes assembled on the H2a/112 pre-mRNA containing
the same HDE yielded only a small amount of the U7 snRNA,
about 10% of the control levels but significantly higher than
the background level (Fig. 6C, lane 4). The small amount of U7
snRNP stably associated with the H2a/112 pre-mRNA prob-
ably represents a complex formed independently of SLBP. The
basal level of the U7 snRNP binding to the HDE is most likely
responsible for residual processing of the H2a/112 pre-mRNA
at heterogeneous sites and less than 10% efficient processing of
the H2a pre-mRNA at the normal site in the absence of bound
SLBP. We conclude that formation of a stable complex of U7
snRNP with the HDE is very inefficient without the assistance
of SLBP bound close to the HDE. Thus, one role of the SLBP
in histone pre-mRNA processing is to help recruit U7 snRNP
into a stable complex on histone pre-mRNA. SLBP-mediated
stabilization of the interaction between the U7 snRNP and the
histone pre-mRNA is not dependent on the HLF. Brief treat-
ment of a nuclear extract at 50°C results in inactivation of this
essential processing factor (12), and in our hands resulted in
only a 50% reduction in the amount of SLBP activity as judged
by mobility shift and has no effect on the U7 snRNP (12, 23).
Although the heat-treated extract was completely inactive in
processing (data not shown), the U7 snRNP still formed a
stable complex with the histone pre-mRNA with only a slightly
reduced efficiency compared to the control extract (Fig. 6D,
lanes 3 and 2, respectively). Thus, the heat-labile factor is not
essential for formation of the complex containing the histone
pre-mRNA, SLBP, and U7 snRNP.
DISCUSSION
We (45) and others (20) have previously reported the clon-
ing and preliminary analysis of the SLBP, a trans-acting factor
which plays an important role in 39-end processing of the
replication-dependent histone pre-mRNAs. SLBP is not simi-
lar to any other protein in the database and contains a novel
RNA binding domain. Here we have determined the regions of
SLBP required for histone pre-mRNA processing and a role of
SLBP in the processing reaction.
A 93-amino-acid region of SLBP supports efficient in vitro
processing. The processing activity of extracts depleted by ei-
ther a biotinylated stem-loop or anti-SLBP was efficiently re-
stored by addition of the full-length human SLBP expressed in
Sf9 insect cells by using the baculovirus system. The ability of
purified SLBP to complement the depleted extract indicates
that no other component of the processing machinery is re-
moved from the extract during the depletion procedure. This
suggests that the HBF, which has previously been functionally
defined as the factor which interacts with the stem-loop (41), is
comprised only of SLBP.
SLBP contains a 73-amino-acid region in the center of the
protein responsible for binding to the stem-loop sequence in
histone pre-mRNAs. The entire amino-terminal region of the
SLBP can be removed without affecting 39-end histone pre-
mRNA processing in vitro. This 124-amino-acid region may
play a role in some of the other processes in histone mRNA
metabolism, such as nucleocytoplasmic transport of the histone
mRNP, translation, or regulation of histone mRNA stability.
The RNA binding domain alone was not sufficient to support
processing, but the addition of only 20 amino acids to the
C-terminal side of the RNA binding domain restored about
50% of the activity of the intact SLBP. Additional amino acids
in the C-terminal region of SLBP must contribute to the max-
imal activity of the protein. Replacement of this entire 20-
amino-acid region in the context of the full-length SLBP
greatly reduced processing without affecting its ability to bind
RNA.
Processing of the H1t pre-mRNA is fully dependent on
SLBP. SLBP (HBF) is required for maximal processing effi-
ciency of all commonly used histone pre-mRNA substrates,
including H2a-614, H3-614, H3-53, H4-1, and H4-12 pre-
mRNAs (38). In the absence of SLBP, processing occurs at a
reduced rate. In contrast, the H1t pre-mRNA substrate is
processed with efficiency similar to that of the H2a-614 histone
pre-mRNA in the complete extract but is absolutely dependent
on SLBP for processing. The strength of the HDE is also
important for high efficiency of processing in vivo. For exam-
ple, the H2a-614 pre-mRNA capable of forming with the U7
snRNA 14 bp (including 2 GU bp) is expressed very efficiently
in vivo (13). Other histone pre-mRNAs that have much weaker
HDEs (18, 45) are expressed at a lower level in vivo, partly due
to a decreased efficiency of 39-end formation (18).
The U7 snRNP forms a stable complex with the histone
pre-mRNA and SLBP. Processing of histone pre-mRNA in-
volves assembly of a multifactor complex on the histone pre-
mRNA, followed by cleavage of the histone pre-mRNA (23).
Since SLBP alone can form a stable complex with histone
pre-mRNA, the initial event in processing in vivo is likely
binding of the SLBP. The immunoprecipitation experiments
with the anti-SLBP antibody allowed us to detect formation of
a stable complex containing at least three components: SLBP,
the pre-mRNA substrate, and the U7 snRNP. This complex
was formed rapidly and was resistant to extensive washing with
isotonic solutions containing nonionic detergents. Stable bind-
ing of the U7 snRNP to the pre-mRNA was absolutely depen-
dent on formation of a duplex RNA between the U7 snRNA
and the HDE. While these results confirm that the HDE is a
primary site of binding for the U7 snRNP, they do not preclude
existence of an independent but weaker binding of the U7
snRNP to the stem-loop (or stem-loop–SLBP complex) in the
initial phase of the processing reaction, as suggested previously
by a combination of RNase protection and anti-Sm-mediated
immunoprecipitation experiments (26). Such an interaction,
which could involve protein-protein interactions between
SLBP and a protein in U7 snRNP, might be disrupted by the
stringent washing conditions used during our immunoprecipi-
tation experiments.
In agreement with previous observations (23), the efficiency
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of complex formation was dependent on the stability of the
RNA duplex formed between the 59 end of the U7 snRNA and
the HDE. In the immunoprecipitation experiments, about 20%
of the total U7 snRNP in the extract and 3% of the H2a-614
pre-mRNA substrate are involved in formation of stable com-
plexes. SLBP was present in the extract in excess of the sub-
strate, and all of the substrate was precipitated by the anti-
SLBP antibody, ruling out the possibility that there are
substrate molecules that form a stable complex only with U7
snRNP. The histone H1t pre-mRNA also formed a stable
complex with SLBP and U7 snRNP, although less efficiently,
despite the fact that the H1t HDE alone could not stably
interact with the U7 snRNP (Fig. 2B). These results suggest
that stable binding of the U7 snRNP to the H1t pre-mRNA is
dependent on additional interactions with SLBP, presumably
due to protein-protein interactions with a protein(s) in the U7
snRNP.
Subsequent to formation of the complex containing the pre-
mRNA, SLBP and the U7 snRNP, additional factors must be
recruited for cleavage to occur. Since only a small fraction of
the substrate and a large fraction of the U7 snRNP are present
in the complex, the same U7 snRNP must function in cleavage
of multiple substrates during the 1 h in vitro reaction incuba-
tion, which normally yields more than 50% of the mature
product. It is not necessary for assembly of the complex that
the substrate be cleavable.
Proper spacing between the stem-loop and the HDE is nec-
essary for stable binding of U7 snRNP. A role for SLBP in
stabilizing the interaction between the U7 snRNP and pre-
mRNA was first suggested by the observation that pre-mRNAs
with weak HDEs are more dependent on SLBP (HBF) (38).
This role of SLBP (HBF) was further supported by demon-
strating that mutations within the HDE which allowed more
extensive base pairing with the U7 snRNA resulted in a re-
duced requirement for SLBP (38). Additional experimental
support for the role of SLBP in recruiting the U7 snRNP to
pre-mRNA substrates with weak HDE is provided by the im-
munoprecipitation experiments with the H2a/112 pre-mRNA.
Insertion of 12 nucleotides between the stem-loop sequence
and the HDE virtually abolished processing, most likely by
precluding productive interaction between factors binding to
both elements. The failure to process the H2a/112 pre-mRNA
was accompanied by significant reduction in the amount of the
U7 snRNP coassembled on this substrate. These experiments
provide direct biochemical evidence that stable association of
the U7 snRNP with the histone pre-mRNA is not determined
solely by the sequence of the HDE but is stimulated by SLBP
bound to the stem-loop sequence at the appropriate distance
from the HDE.
In a previous study with psoralen cross-linking and immu-
noprecipitation with antitrimethylguanosine antibodies, no dif-
ference was observed in the ability of the U7 snRNP to bind
H2a-614 mutant pre-mRNAs containing variable insertions be-
tween the stem-loop sequence and the HDE (31). These ex-
periments were performed under processing conditions, and
indeed there was more U7 snRNP bound to the substrates that
were not efficiently cleaved than to the wild-type H2a-614
substrate (31). Our results show a clear dependence on the
proper positioning of the HDE for stable U7 snRNP binding to
the H2a-614 pre-mRNA (Fig. 6). This discrepancy is most
likely due to efficient processing of the wild-type substrate
under the conditions used by Scharl and Steitz, which would
result in rapid dissociation of complexes containing the U7
snRNP (31). During the short time and at the lower temper-
ature (22°C) we used, there is complex formation but virtually
no cleavage. We believe this complex is on the pathway to
histone pre-mRNA processing, since subsequent warming of
the reaction sample results in efficient processing. We observed
a low level of binding of the U7 snRNP to the H2a/112
substrate, which is probably due solely to base pairing of the
U7 snRNA with the HDE and occurs independently of SLBP.
Efficient processing requires high-affinity binding of SLBP.
Stabilization of binding of the U7 snRNP to the HDE by
SLBP requires that SLBP binds to the stem-loop sequence
on the same pre-mRNA molecule. Substrates which lack
strong SLBP binding sites are processed less efficiently, and a
reduction of 5- to 10-fold in the affinity of SLBP for the stem-
loop has a large effect on processing efficiency, even on the
efficient H2a-614 substrate, in vitro (Fig. 1) and in vivo (30).
An increase in the off rate of SLBP effected by a reduction in
affinity suggests that the formation and assembly of the initial
stable processing complex requires binding of SLBP to the
pre-mRNA for a significant amount of time. The affinity of
both SLBP and U7 snRNP for their respective sites on the
histone pre-mRNA is critical for determining the rate of the in
vitro processing reaction. If the U7 snRNP binds stably to the
pre-mRNA due to a high degree of complementarity between
the HDE and the 59 end of U7 snRNA, then it can also recruit
the additional factors necessary for processing, albeit with
lower efficiency.
An initially puzzling result, that the U4C and 59FL RNA
competitors have very different effects on processing of the
H2a-614 pre-mRNA and the H1t mRNA, is understandable in
this scenario. In the case of the H2a-614 pre-mRNA, U7
snRNP associates with the HDE relatively stably. Binding of
the small amount of free SLBP present in the reaction mixture
containing competitors is sufficient to form significant amounts
of a stable processing complex, which is resistant to the com-
petitors. In contrast, the U7 snRNP does not associate for a
significant amount of time with the H1t pre-mRNA; rather, the
formation of the processing complex is absolutely dependent
on bound SLBP, which is greatly reduced in the presence of the
competitors. U7 snRNP bound stably to the histone pre-
mRNA is also capable of ultimately recruiting the other factors
necessary for processing in the absence of SLBP, although the
formation of the stable complex is greatly enhanced by the
presence of SLBP. These results are consistent with previous
results that suggested cooperative binding of SLBP and U7
snRNP to the histone pre-mRNA (25, 26, 41) and provide
additional evidence for interaction between these two trans-
acting factors in 39-end processing.
Other trans-acting factors involved in histone pre-mRNA
processing. The immunoprecipitation experiments with anti-
SLBP antibody revealed that formation of stable processing
complexes containing the histone pre-mRNA and the U7
snRNP is not dependent on the HLF, the third known trans-
acting processing factor (12). How many other components are
necessary for 39-end processing of the histone pre-mRNAs? A
large number of polypeptides are required for cleavage of
the other pre-mRNAs prior to polyadenylation, although no
snRNA is required in this reaction (16, 19, 42). The coimmu-
noprecipitation procedure with anti-SLBP and a nuclear ex-
tract labeled with [35S]methionine may allow detection of
other factors coassembled with U7 snRNP on the histone pre-
mRNA. These experiments are in progress.
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